Concepedia

Ying Grace Li

YG

Statistics

Publications

3

Citations

216

H-Index

3

Active since

2007

Affiliations

Eli Lilly (United States)(Current)

Ying Grace Li is an author at Eli Lilly (United States) specializing in pharmacokinetics, pharmacology, and clinical pharmacology.

Publications per year

2007–2023

3

Publications

3

Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel

Christopher D. Payne, Ying Grace Li, David S. Small et al. · Journal of Cardiovascular Pharmacology · 2007 · 167 citations

, , +17

First‐in‐Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID‐19

Peter Chen, Gourab Datta, Ying Grace Li et al. · Clinical Pharmacology & Therapeutics · 2021 · 32 citations · Full text

, , +15

Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies

Garrett R. Mullins, Michael E. Hodsdon, Ying Grace Li et al. · The Journal of Clinical Endocrinology & Metabolism · 2023 · 17 citations · Full text

, , +17

1–3 of 3